Zimmer Biomet Holdings, Inc. (BVMF:Z1BH34)

Brazil flag Brazil · Delayed Price · Currency is BRL
123.96
0.00 (0.00%)
At close: Nov 21, 2025
-16.29%
Market Cap 97.84B
Revenue (ttm) 42.69B
Net Income (ttm) 4.29B
Shares Out n/a
EPS (ttm) 21.49
PE Ratio 22.80
Forward PE 11.06
Dividend 0.91 (0.79%)
Ex-Dividend Date Sep 29, 2025
Volume 114
Average Volume 51
Open 123.96
Previous Close n/a
Day's Range 123.96 - 123.96
52-Week Range 115.00 - 157.60
Beta 0.61
RSI 37.37
Earnings Date Feb 5, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1927
Employees 17,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol Z1BH34
Full Company Profile

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD Financial Statements

News

There is no news available yet.